Comments opposing Medicare's efforts to lower U.S. drug prices provide a roadmap to potential legal challenges ahead.
Sentara RMH Medical Center recently earned two honors, garnering national recognition for the hospital.
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% ...
Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 24th February 2026.
Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Click here to find out why HIMS is a Strong Buy.